Beta-lactam therapeutic drug monitoring for OPAT patients
Abstract:
Beta-lactam therapeutic drug monitoring has been growing in prevalence in the acute care hospital setting. Expansion of its use to outpatient parenteral antimicrobial therapy requires careful consideration of potential logistical and therapeutic barriers.
Reference:Childs-Kean LM, Rivera CG, Venugopalan V, Johnson MJ, Barreto EF. The OPAT opportunity for beta-lactam individualization. Antimicrob Steward Healthc Epidemiol. 2024 Sep 4;4(1):e115. doi: 10.1017/ash.2024.367. PMID: 39257422; PMCID: PMC11384153.